Cells are considered as the basic unit of life. The study of different cell structures is called cell biology. The understanding of cells and their components is crucial as several patterns can be observed and several compounds can be discovered. This could contribute to the discovery of new treatments or advancements of existing treatments. Cell biology can also help increase target population and enhance the mechanism of action (MOA) to reduce treatment time.
Technavio’s analysts forecast the global cell lysis market to grow at a CAGR of 7.54% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global cell lysis market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of instruments and consumables that are used for cell lysis.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio’s report, Global Cell Lysis Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors • Becton, Dickinson and Company • Cell Signaling Technology • F. Hoffmann–La Roche • Miltenyi Biotec • Omni International • Qiagen • Qsonica
Market driver • Expanding biotechnology industry • For a full, detailed list, view our report
Market challenge • Excessive cost of cell-based research • For a full, detailed list, view our report
Market trend • Emergence of unique methods of cell disruption • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
The Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization...
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector. Understanding the flexibility...
The custom antibody market in Asia Pacific is expected to grow from US$ 82.3 million in 2021 to US$ 174.8 million by 2028; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. Growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are enhancing...
Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...
The custom antibody market in Middle East and Africa is expected to grow from US$ 14.0 million in 2021 to US$ 25.0 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. Growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are...
The custom antibody market in Europe is expected to grow from US$ 102.5 million in 2021 to US$ 213.7 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Advancements in medical technologies support faster and highly efficient discoveries in antibody development, which can be further customized as per the customers’...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Cleanroom Consumables Market 2021-2025
The analyst has been monitoring the cleanroom consumables market and it is poised to grow by USD 4.61 bn during 2021-2025, progressing at a CAGR of 6.06% during the forecast period. Our report on the cleanroom consumables market provides a holistic analysis, market size and...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.